# PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Sentinel™ Device

Study · id `cardio:ct-nct02895737` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02895737](<https://clinicaltrials.gov/study/NCT02895737>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02895737

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 328 participants.

## Technical summary

Registry record NCT02895737. Randomized; single masking; primary purpose supportive care. Start 2016-12-28 (actual); primary completion 2021-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 328 participants (planned count; ClinicalTrials.gov record NCT02895737, source copy `cardio:ctgov-nct02895737-2021-03-04`, retrieved 2026-10-26)
- Started: 2016-12-28 (actual) (ClinicalTrials.gov record NCT02895737, source copy `cardio:ctgov-nct02895737-2021-03-04`, retrieved 2026-10-26)
- Primary completion: 2021-12 (anticipated) (ClinicalTrials.gov record NCT02895737, source copy `cardio:ctgov-nct02895737-2021-03-04`, retrieved 2026-10-26)
- Completion: 2022-06 (anticipated) (ClinicalTrials.gov record NCT02895737, source copy `cardio:ctgov-nct02895737-2021-03-04`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT02895737, source copy `cardio:ctgov-nct02895737-2021-03-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02895737-2021-03-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Sentinel™ Device
- Acronym: PROTECT
- Condition: Cerebral Embolization During TAVI Using Balloon-expandable vs. Self-expandable Valves
- Intervention (Device): TAVI: Edwards SAPIEN 3, Edwards Lifesciences, Edwards Sapien Ultra
- Intervention (Device): TAVI: Edwards SAPIEN 3, Edwards Lifesciences, Edwards Sapien Ultra; Sentinel™ Cerebral Protection Systems
- Intervention (Device): TAVI: CoreValve® Evolut R™, CoreValve Medtronic
- Intervention (Device): TAVI: CoreValve® Evolut R™, CoreValve Medtronic; Sentinel™ Cerebral Protection Systems
- Lead sponsor: Deutsches Herzzentrum Muenchen
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Deutsches Herzzentrum Muenchen (`cardio:org-deutsches-herzzentrum-muenchen`)

## Provenance

Content hash: b7efc2061bb19ce40c5f4fb61426da17c9858f2cb4c98d040116a5de2938321e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
